# Safety and Pharmacokinetics of VT-1598

> **NCT04208321** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 48 (actual)

## Conditions studied

- Coccidioidomycosis

## Interventions

- **OTHER:** Placebo
- **DRUG:** VT-1598

## Key facts

- **NCT ID:** NCT04208321
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-29
- **Primary completion:** 2021-12-27
- **Final completion:** 2021-12-27
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2024-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04208321

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04208321, "Safety and Pharmacokinetics of VT-1598". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04208321. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*